We have recently issued a press release detailing our reglan side effects lawsuit for tardive dyskinesia sufferers. The text of the press release which can be read at PR Web’s site is as follows:
Gregory & Swapp PLLC now represents clients who have been injured by the prescription drug Reglan, announces Managing Partner J. Craig Swapp. With the FDA’s recent black box warning for the drug Reglan, the law firm has introduced a Reglan lawsuit website to help inform individuals of the dangers of the drug and what legal options are available to those injured by its side effects.
Reglan is a popular prescription drug used by millions of people to deal with gastrointestinal problems in adults. Unfortunately, according to the FDA’s black box warning, the prolonged use of Reglan has been linked to the development of Tardive Dyskinesia. Tardive Dyskinesia is a serious and often irreversible movement disorder, with involuntary body twitching such as repetitive movement of extremities, facial ticks, constant lip-smacking, unintentional grimacing of the face, tongue protrusion, rapid eye movement or blinking, puckering of the lips and impaired finger movement. People suffering from Tardive Dyskinesia often withdraw from social contact, and can be affected emotionally and psychologically – leading to severe depression.
For updates concerning Reglan side effects, please visit this web link.
Reglan is the trade name for metoclopramide, a prescription drug used to treat gastrointestinal problems in adults, such as diabetic gastropaesis, delayed gastric emptying, and GERD (Acid Reflux Disease). Metoclopramide is a dopamine antagonist which is intended to increase lower esophageal sphincter pressure and thus improve gastrointestinal emptying. The FDA approved Reglan in 1985 for short-term treatment (between 4 and 12 weeks) of these conditions only after other treatment methods have failed.
Some evidence indicates that a third of patients taking Reglan were prescribed the drug for longer than 12 weeks. Of those long-term patients, about 20% developed some form of Tardive Dyskinesia (Western Journal of Medicine). Recent studies have indicated that up to 2 million people were prescribed Reglan or its generic equivalents. The elderly are especially susceptible to the medication. Reglan is manufactured by Baxter Healthcare Corporation and several generic versions are manufactured by Wyeth, Pliva, Schwarz Pharma, and Teva Pharmaceuticals.
The Law Firm of Gregory & Swapp PLLC handles serious personal injury cases, including dangerous prescription drugs, wrongful death, vehicle accidents, etc. For more information please visit Gregory & Swapp’s Tardive Dyskinesia website or call 1-800-404-9000.